KR20020013473A - 아데노바이러스-매개 유전자 치료법 - Google Patents

아데노바이러스-매개 유전자 치료법 Download PDF

Info

Publication number
KR20020013473A
KR20020013473A KR1020017004945A KR20017004945A KR20020013473A KR 20020013473 A KR20020013473 A KR 20020013473A KR 1020017004945 A KR1020017004945 A KR 1020017004945A KR 20017004945 A KR20017004945 A KR 20017004945A KR 20020013473 A KR20020013473 A KR 20020013473A
Authority
KR
South Korea
Prior art keywords
adenovirus
tumor
medicament
patients
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017004945A
Other languages
English (en)
Korean (ko)
Inventor
셉포 이라-허투아라
애뉴-마리아 샌드마일
새미 로이마스
마티 바파라흐티
Original Assignee
추후제출
아크 테라퓨틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20020013473(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 추후제출, 아크 테라퓨틱스 리미티드 filed Critical 추후제출
Publication of KR20020013473A publication Critical patent/KR20020013473A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020017004945A 1998-11-06 1999-11-05 아데노바이러스-매개 유전자 치료법 Ceased KR20020013473A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824437.9A GB9824437D0 (en) 1998-11-06 1998-11-06 Gene therapy
GB9824437.9 1998-11-06
PCT/EP1999/009017 WO2000028059A1 (en) 1998-11-06 1999-11-05 Adenovirus-mediated gene therapy

Publications (1)

Publication Number Publication Date
KR20020013473A true KR20020013473A (ko) 2002-02-20

Family

ID=10842035

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017004945A Ceased KR20020013473A (ko) 1998-11-06 1999-11-05 아데노바이러스-매개 유전자 치료법

Country Status (18)

Country Link
US (1) US6579855B1 (cg-RX-API-DMAC7.html)
EP (1) EP1135513B2 (cg-RX-API-DMAC7.html)
JP (1) JP4733833B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020013473A (cg-RX-API-DMAC7.html)
CN (1) CN1184321C (cg-RX-API-DMAC7.html)
AT (1) ATE341639T1 (cg-RX-API-DMAC7.html)
AU (1) AU749451B2 (cg-RX-API-DMAC7.html)
CA (1) CA2348624C (cg-RX-API-DMAC7.html)
CY (1) CY1106198T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933468T3 (cg-RX-API-DMAC7.html)
DK (1) DK1135513T4 (cg-RX-API-DMAC7.html)
ES (1) ES2273521T5 (cg-RX-API-DMAC7.html)
GB (1) GB9824437D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0104046A3 (cg-RX-API-DMAC7.html)
NO (1) NO330776B1 (cg-RX-API-DMAC7.html)
PL (1) PL193076B1 (cg-RX-API-DMAC7.html)
PT (1) PT1135513E (cg-RX-API-DMAC7.html)
WO (1) WO2000028059A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910950D0 (en) 2009-06-24 2009-08-05 Ark Therapeutics Ltd Filtration
GB0916997D0 (en) * 2009-09-28 2009-11-11 Ark Therapeutics Ltd Combination therapy
US20130296407A1 (en) * 2011-01-18 2013-11-07 Ark Therapeutics, Ltd. Combination Therapy for Cancer
GB201100804D0 (en) * 2011-01-18 2011-03-02 Ark Therapeutics Ltd Drug combination
SG10201604810UA (en) 2012-02-07 2016-08-30 Global Bio Therapeutics Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
US20160058888A1 (en) * 2013-05-08 2016-03-03 Gliotherapy Limited Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
CN105813579B (zh) 2013-08-08 2019-05-07 全球生物疗法有限公司 用于微创手术过程的夹具装置和其应用
DE102019000490A1 (de) 2019-01-23 2020-07-23 HAEMES Verwaltungsgesellschaft mbH Verwendung von Oligonukleotiden für die Behandlung von Tumoren
IL293978A (en) 2019-12-20 2022-08-01 Regeneron Pharma New il2 agonists and methods of using them
KR20230009430A (ko) 2020-05-12 2023-01-17 리제너론 파아마슈티컬스, 인크. 신규 il10 효능제 및 그의 사용 방법
CN117597365A (zh) 2021-05-04 2024-02-23 再生元制药公司 多特异性fgf21受体激动剂及其应用
AU2022314734A1 (en) 2021-07-19 2024-02-08 Regeneron Pharmaceuticals, Inc. Il12 receptor agonists and methods of use thereof
US12559576B2 (en) 2021-11-11 2026-02-24 Regeneron Pharmaceuticals, Inc. CD20-PD1 binding molecules and methods of use thereof
AU2024207005A1 (en) 2023-01-13 2025-08-28 Regeneron Pharmaceuticals, Inc. Il12 receptor agonists and methods of use thereof
CN121002062A (zh) 2023-01-13 2025-11-21 再生元制药公司 Fgfr3结合分子及其使用方法
IL322890A (en) 2023-02-28 2025-10-01 Regeneron Pharma Multispecific molecules containing an MHC-peptide complex containing an MHC domain and an antigenic peptide and a partially targeted immune cell antigen
WO2024233926A1 (en) 2023-05-10 2024-11-14 Regeneron Pharmaceuticals, Inc. Cd20-pd1 binding molecules and methods of use thereof
KR20260113057A (ko) 2023-11-14 2026-07-21 리제너론 파아마슈티컬스, 인크. 조작된 중쇄 가변 도메인 및 이의 용도
WO2025240335A1 (en) 2024-05-13 2025-11-20 Regeneron Pharmaceuticals, Inc. Fgfr3 binding molecules and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662441B2 (ja) * 1986-02-18 1994-08-17 花王株式会社 抗腫瘍物質徐放性製剤
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk

Also Published As

Publication number Publication date
US6579855B1 (en) 2003-06-17
AU749451B2 (en) 2002-06-27
PT1135513E (pt) 2006-12-29
DE69933468D1 (de) 2006-11-16
HUP0104046A3 (en) 2003-09-29
ES2273521T5 (es) 2011-12-28
CY1106198T1 (el) 2011-06-08
CN1325450A (zh) 2001-12-05
DE69933468T2 (de) 2007-01-11
CA2348624A1 (en) 2000-05-18
NO20012220L (no) 2001-05-04
NO20012220D0 (no) 2001-05-04
AU1385100A (en) 2000-05-29
EP1135513B1 (en) 2006-10-04
ATE341639T1 (de) 2006-10-15
JP4733833B2 (ja) 2011-07-27
PL349489A1 (en) 2002-07-29
PL193076B1 (pl) 2007-01-31
NO330776B1 (no) 2011-07-11
HUP0104046A2 (hu) 2002-01-28
EP1135513B2 (en) 2011-08-10
DE69933468T3 (de) 2012-01-19
CN1184321C (zh) 2005-01-12
DK1135513T4 (da) 2011-11-21
DK1135513T3 (da) 2006-11-27
WO2000028059A1 (en) 2000-05-18
GB9824437D0 (en) 1999-01-06
ES2273521T3 (es) 2007-05-01
CA2348624C (en) 2012-07-31
JP2002529097A (ja) 2002-09-10
EP1135513A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
JP4733833B2 (ja) アデノウィルスを介する遺伝子治療
JP3778930B2 (ja) 動脈平滑筋細胞増殖の抑制
EP0454781B1 (en) Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5861290A (en) Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
JP3755827B2 (ja) 組み込み可能な組み換えアデノウィルス、それらの製造及びそれらの治療的利用
EP0755454B1 (en) Aav-mediated delivery of dna to cells of the nervous system
ES2744565T3 (es) Tratamiento de la hiperbilirrubinemia
JP2003277272A (ja) DNA損傷剤およびр53を含有する組成物
JP2018509164A (ja) 組換えGlut1アデノ随伴ウイルスベクターコンストラクトおよびGlut1発現を回復させる方法
CN112639108A (zh) 治疗非综合征性感觉神经性听力损失的方法
US6423692B2 (en) Method of enhancing the effectiveness of DCK phosphorylated molecules
EP4347791A1 (en) Drug for genetic and gene-cell-based therapy
JPH11514884A (ja) 腫瘍にあるサイクリンg1の発現
JP2002516607A (ja) 延髄運動ニューロン中へのアデノウイルス性ベクター媒介遺伝子転移
Shimizu et al. Infectious retrovirus is inactivated by serum but not by cerebrospinal fluid or fluid from tumor bed in patients with malignant glioma
US20230078498A1 (en) Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis
KR100403893B1 (ko) 글루타메이트 디 카르복실라제(gad) 활성을 암호화하는 재조합바이러스
MXPA01004410A (es) Terapia de gen mediada por adenovirus
Lowenstein et al. Gene therapy for neurological disorders
WO2022011099A1 (en) Modified hexosaminidase and uses thereof
MXPA99004305A (en) Treatment of diabetes with transcription factor gene

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010420

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040906

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060530

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20061229

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060530

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20070131

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20061229

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070728

Appeal identifier: 2007101001276

Request date: 20070131

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070131

Effective date: 20070728

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20070730

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20070131

Decision date: 20070728

Appeal identifier: 2007101001276

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Patent event date: 20070730

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20080822

Appeal identifier: 2007201007723

Request date: 20070830

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070830

Effective date: 20080822

PJ1302 Judgment (patent court)

Patent event date: 20080904

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20070830

Decision date: 20080822

Appeal identifier: 2007201007723

Appeal kind category: Appeal against decision to decline refusal

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2002 Appeal before the supreme court

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event date: 20070730

Patent event code: PJ20021S01I

Request date: 20080918

Appeal identifier: 2008301003797

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20090130

J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080918

Effective date: 20090130

PJ1303 Judgment (supreme court)

Comment text: Written Judgment (Supreme Court)

Patent event date: 20090203

Patent event code: PJ13031S01D

Decision date: 20090130

Appeal kind category: Appeal against decision to decline refusal

Request date: 20080918

Appeal identifier: 2008301003797